⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

IBM IBM

United States Technology
5.9/10
AI Analyst score
225.51 USD
Last price at analysis date · analyst target 240.59 (+6.7%)
🛒 Where to buy IBMPartner brokers · US (NYSE/Nasdaq) · sample 200.00 € orderUS (NYSE/Nasdaq)
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; valuation is reasonable (PE 20.1) but weak growth and the Z mainframe probe limit upside potential.

IBM is a multinational technology company offering software, infrastructure, and consulting services, with a growing focus on artificial intelligence and hybrid cloud solutions for enterprises. IBM trades with a tight financial health (net debt/EBITDA of 3.47) and stalled growth (revenue +1.1%, earnings -1.8%), but its quality is solid (ROE 34.5%) and its dividend is well covered (payout 59.8%).

Financial health
4.2
Quality / Moat
7.4
Valuation
6.3
Growth
4.3
Dividend
7.3
Momentum
3.9
Risk & Context
7.2

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E20.05
Fwd P/E17.15
EV/EBITDA16.37
P/B6.17
P/S3.07
PEG2.13
Market cap212.46 B USD
Enterprise value269.69 B USD
🏰 Quality and moat
ROIC (approx.)11.5%
Gross margin58.10%
FCF conversion73%
Operating margin16.55%
📈 Profitability and margins
ROE34.46%
ROA5.30%
Net margin15.52%
FCF12.05 B USD
FCF yield5.67%
🏦 Solvency and liquidity
Total debt65.27 B USD
Net debt57.14 B USD
Cash8.13 B USD
EBITDA16.47 B USD
Net debt / EBITDA3.47
D/E188.97
Current ratio0.79
Quick ratio0.61
🚀 Growth
Revenue growth1.10%
Earnings growth-1.80%
EPS (TTM)11.25 USD
EPS (Fwd)13.15 USD
💰 Dividend and risk
Dividend yield3.00%
Payout59.8%
Beta0.71
Analyst consensusBuy (22)
Target price240.59 USD
52-week range199.19 USD – 332.46 USD
⚠️ Main risk: The investigation into Z mainframe disclosure risks could lead to fines or legal costs, impacting confidence and results.
See the full analysis and compare with the rest of the ranking →

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

IBM is a multinational technology company offering software, infrastructure, and consulting services, with a growing focus on artificial intelligence and hybrid cloud solutions for enterprises. IBM trades with a tight financial health (net debt/EBITDA of 3.47) and stalled growth (revenue +1.1%, earnings -1.8%), but its quality is solid (ROE 34.5%) and its dividend is well covered (payout 59.8%).

Score by category

CategoryScore
Financial health4.2
Quality / Moat7.4
Valuation6.3
Growth4.3
Dividend7.3
Momentum3.9
Risk & Context7.2

OVERALL SCORE: 5.9/10

Context and risks

The investigation into Z mainframe disclosure risks adds a specific legal/regulatory risk. Additionally, the weakness in the tech sector due to geopolitical tensions and AI doubts pressures IBM's momentum.

News considered in the analysis

  • Nvidia’s CEO Expects AI-Powered Cybersecurity to Boom. These 2 Companies Are Poised to Get a Big Boost From the Trend. — La mención de IBM como beneficiaria de la ciberseguridad impulsada por IA es un viento de cola moderado, pero el titular es genérico y no aporta un contrato o producto concreto.
  • IBM’s Dividend Survived the Old IBM. Can It Survive the New One? — Artículo especulativo sobre la sostenibilidad del dividendo; no aporta hechos nuevos y el dividendo ya está puntuado por el motor.
  • Stellar Surpasses Its 50-Week Average, While XRP Lags: Which Payments Coin Will Lead Into Q4? — Ruido sobre criptomonedas sin relación con el negocio de IBM.
  • International Business Machines (IBM) Faces Probe Over Z Mainframe Disclosure Risks — Una investigación sobre riesgos de divulgación de su mainframe Z es un riesgo legal/regulatorio material que podría afectar a la confianza y a los costes, aunque aún no se ha resuelto.
  • Quantum Is a $850 Billion Dream. Microsoft and Amazon Are Betting Big on It. — La oportunidad de la computación cuántica es relevante para IBM, pero el titular se centra en Microsoft y Amazon; el impacto en IBM es indirecto y a largo plazo.

Verdict: Hold; valuation is reasonable (PE 20.1) but weak growth and the Z mainframe probe limit upside potential.

Main risk: The investigation into Z mainframe disclosure risks could lead to fines or legal costs, impacting confidence and results.

Other Technology companies

Neighbours in the sector ranking, to compare without going back to the index.

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.